Pharmalink has a reputation for developing new and innovative extracts. We make sure that your company is offered the products matching current and future market trends.

Pharmalink have international experience with sales, logistics and regulatory issues. We also offer a consultancy service to companies wanting to research the availability of European Drug Master Files and European market entry.

 

Innovation

Pharmalink has a successful track record in introducing new
and innovative products.

In 2005 our Kiwi-Seed Omega 3 Oil (developed in a Joint
Venture with Flavex and Vital Food Processors) got awarded
the Frost & Sullivan Price for Innovation.

In 2005 we developed ‘Deep Sea Fish Omega 3’ in conjunction
with CTPP. This Marine product is specially rich in
Alkylglycerols.

In 2002 Lyprinol®, a stabilised and patented Marine-Lipid
Extract was registered by the EU as the first natural
anti-inflammatory for treatment of Arthritis (as a balanced
dietary supplement).

Pharmalink was the first company to introduce New Zealand
Greenshell Mussel Powder into the German market – today a
top seller in many consumer markets.

10 years ago we introduced the highly anti-microbial Manuka
Oil into the German Market. This essential oil has since then
been formulated into many successful foot and skincare
products.